Skip to content
healthcare.dev

ABILIFY

NDC 59148-009, ARIPIPRAZOLE, tablet, from Otsuka America Pharmaceutical, Inc..

Product NDC
59148-009
Status
Listed
Labeler
Otsuka America Pharmaceutical, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA021436
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/59148-009 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ARIPIPRAZOLE15 mg/1

Pharmacologic classes

Atypical Antipsychotic [EPC]

Package NDCNDC-11Package
59148-009-135914800091330 TABLET in 1 BOTTLE, PLASTIC (59148-009-13)
59148-009-3559148000935100 TABLET in 1 BLISTER PACK (59148-009-35)
59148-009-95591480009957 TABLET in 1 BLISTER PACK (59148-009-95)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c040bd1d-45b7-49f2-93ea-aed7220b30ac
  • NADAC price for package 59148000913

    GET /v1/drugs/nadac/59148000913

Use it

Look up 59148-009 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/59148-009 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 59148-009. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.